Weiwei Wu

849 total citations
69 papers, 467 citations indexed

About

Weiwei Wu is a scholar working on Genetics, Molecular Biology and Epidemiology. According to data from OpenAlex, Weiwei Wu has authored 69 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Genetics, 21 papers in Molecular Biology and 12 papers in Epidemiology. Recurrent topics in Weiwei Wu's work include Forensic and Genetic Research (17 papers), Molecular Biology Techniques and Applications (9 papers) and Yersinia bacterium, plague, ectoparasites research (8 papers). Weiwei Wu is often cited by papers focused on Forensic and Genetic Research (17 papers), Molecular Biology Techniques and Applications (9 papers) and Yersinia bacterium, plague, ectoparasites research (8 papers). Weiwei Wu collaborates with scholars based in China, Australia and Canada. Weiwei Wu's co-authors include De-Jian Lü, Qiuling Liu, Hu Zhao, Weihan Zhang, Yuan Jin, Jinjuan Li, Zhigang Li, Jianding Cheng, Ling Chen and Caiyun Zhou and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Nano and PLoS ONE.

In The Last Decade

Weiwei Wu

61 papers receiving 457 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiwei Wu China 13 190 167 53 52 31 69 467
Fumi Mineshiba United States 13 122 0.6× 154 0.9× 29 0.5× 41 0.8× 33 1.1× 17 397
Bin Ye China 13 85 0.4× 149 0.9× 78 1.5× 39 0.8× 17 0.5× 29 428
Arijita Jash United States 12 104 0.5× 314 1.9× 37 0.7× 41 0.8× 15 0.5× 21 709
Shaghayegh Baradaran Ghavami Iran 12 143 0.8× 229 1.4× 83 1.6× 74 1.4× 16 0.5× 31 530
Eva d’Hennezel Canada 14 211 1.1× 262 1.6× 98 1.8× 69 1.3× 20 0.6× 18 928
Liliana Íñiguez-Gutiérrez Mexico 6 58 0.3× 237 1.4× 34 0.6× 62 1.2× 81 2.6× 7 664
Ashleigh Goethel Canada 9 160 0.8× 247 1.5× 72 1.4× 76 1.5× 15 0.5× 9 452
Kaushik Ghosh India 10 51 0.3× 127 0.8× 35 0.7× 98 1.9× 43 1.4× 49 484
Caitlin Russell United States 7 195 1.0× 339 2.0× 54 1.0× 115 2.2× 17 0.5× 9 561
Mansour Mohamadzadeh United States 7 85 0.4× 302 1.8× 54 1.0× 44 0.8× 21 0.7× 7 481

Countries citing papers authored by Weiwei Wu

Since Specialization
Citations

This map shows the geographic impact of Weiwei Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Wu more than expected).

Fields of papers citing papers by Weiwei Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiwei Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Wu. The network helps show where Weiwei Wu may publish in the future.

Co-authorship network of co-authors of Weiwei Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Weiwei Wu. A scholar is included among the top collaborators of Weiwei Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiwei Wu. Weiwei Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Wen, et al.. (2025). Histopathological Subtypes and Clinical Presentation of Seborrheic Keratosis: A 15-Year Retrospective Analysis of 1,169 Cases in Hainan, China. Clinical Cosmetic and Investigational Dermatology. Volume 18. 721–727.
2.
Wu, Weiwei, Yan Wang, Feng Qiu, et al.. (2025). A carrier-free long-acting ropivacaine formulation using methylprednisolone sodium succinate as a dual-functional adjuvant. Theranostics. 15(9). 3862–3876.
3.
Zheng, Wenjie, Ming Zhang, Weiwei Wu, Xi Tang, & Zhenyuan Pan. (2024). The Likelihood of Resistant Tinea Capitis Caused by Hortaea Werneckii: A Case Report. Clinical Cosmetic and Investigational Dermatology. Volume 17. 2653–2657. 1 indexed citations
4.
Liu, Jing, Weiwei Wu, Fei Peng, et al.. (2024). Size control of ropivacaine nano/micro-particles by soft-coating with peptide nanosheets for long-acting analgesia. Theranostics. 14(6). 2637–2655. 8 indexed citations
5.
Deng, Bo, Xiaoli Jiang, Bo Yang, et al.. (2024). Caffeic acid mitigates myocardial fibrosis and improves heart function in post-myocardial infarction by inhibiting transforming growth factor-β receptor 1 signaling pathways. Biomedicine & Pharmacotherapy. 177. 117012–117012. 4 indexed citations
6.
Peng, Fei, Jing Liu, Junjie Chen, et al.. (2023). Nanocrystals Slow-Releasing Ropivacaine and Doxorubicin to Synergistically Suppress Tumor Recurrence and Relieve Postoperative Pain. ACS Nano. 17(20). 20135–20152. 16 indexed citations
7.
Zhang, Ming, et al.. (2022). Clinical and Pathological Characteristics of 755 Patients with Skin Cancers in Hainan, China: A 12-Year Retrospective Study. SHILAP Revista de lepidopterología. 2 indexed citations
8.
Duan, Ran, Junrong Liang, Shuai Qin, et al.. (2022). Plague Outbreak of a Marmota himalayana Family Emerging from Hibernation. Vector-Borne and Zoonotic Diseases. 22(8). 410–418. 9 indexed citations
9.
Duan, Ran, Lei Meng, Junrong Liang, et al.. (2022). First Case Report of Human Plague Caused by Excavation, Skinning, and Eating of a Hibernating Marmot (Marmota himalayana). Frontiers in Public Health. 10. 910872–910872. 7 indexed citations
10.
Fan, Haoliang, Ying Zeng, Weiwei Wu, et al.. (2021). The Y‐STR landscape of coastal southeastern Han: Forensic characteristics, haplotype analyses, mutation rates, and population genetics. Electrophoresis. 42(16). 1578–1593. 18 indexed citations
11.
Zhang, Yunfang, et al.. (2021). Pemphigus Herpetiformis-Type Drug Reaction Caused by Programmed Cell Death Protein-1 Inhibitor Treatment. Clinical Cosmetic and Investigational Dermatology. Volume 14. 1125–1129. 4 indexed citations
12.
Wu, Weiwei, et al.. (2021). Wells Syndrome Successfully Treated with Tripterygium Glycosides. Clinical Cosmetic and Investigational Dermatology. Volume 14. 1029–1031. 2 indexed citations
13.
Liang, Junrong, Shuai Qin, Ran Duan, et al.. (2021). A Lytic Yersina pestis Bacteriophage Obtained From the Bone Marrow of Marmota himalayana in a Plague-Focus Area in China. Frontiers in Cellular and Infection Microbiology. 11. 700322–700322. 4 indexed citations
14.
Wu, Weiwei, et al.. (2019). Successful treatment of kerion with itraconazole and ALA-PDT: A case report. Photodiagnosis and Photodynamic Therapy. 27. 385–387. 10 indexed citations
15.
Hua, Sha, Jun Zhang, Jing Li, et al.. (2018). Influence of APOA5 Locus on the Treatment Efficacy of Three Statins: Evidence From a Randomized Pilot Study in Chinese Subjects. Frontiers in Pharmacology. 9. 352–352. 10 indexed citations
16.
Gong, Jie, Meng Xiao, Timothy Kudinha, et al.. (2018). Genetic Differentiation, Diversity, and Drug Susceptibility of Candida krusei. Frontiers in Microbiology. 9. 2717–2717. 20 indexed citations
17.
Wu, Weiwei, et al.. (2017). Design of assessment tables for enteral nutrition care giving during nursing research in children with severe burns. Biomedical Research-tokyo. 28(17). 7419–7426. 1 indexed citations
18.
Liu, Qiuling, Xin He, Yan‐Wei Shi, et al.. (2017). Population structure of Han nationality in Central-Southern China. Forensic Science International Genetics. 29. e1–e3. 2 indexed citations
19.
Wu, Weiwei, Linli Chen, Changhui Liu, et al.. (2016). Development of the 19 X‐STR loci multiplex system and genetic analysis of a Zhejiang Han population in China. Electrophoresis. 37(15-16). 2260–2272. 25 indexed citations
20.
Wu, Weiwei, et al.. (2010). Improving the maternal mortality ratio in Zhejiang Province, China, 1988–2008. Midwifery. 26(5). 544–548. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026